For the year ending 2025-12-31, AURX has $1,845,662 in assets. $2,802,221 in debts. $548,946 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash | 548,946 | |||
| Accounts receivable, net | 561,667 | |||
| Inventory, net | 213,761 | |||
| Prepaid expenses and other current assets | 55,509 | |||
| Total current assets | 1,379,883 | |||
| Property, plant, and equipment, gross | 884,619 | |||
| Less accumulated depreciation | 518,304 | |||
| Property and equipment, net | 366,315 | |||
| Operating lease right of use assets | 99,464 | |||
| Total assets | 1,845,662 | |||
| Accounts payable | 436,083 | |||
| Accrued expenses | 493,792 | |||
| Deferred revenue | 300,000 | |||
| Current portion of operating lease liabilities | 76,410 | |||
| Total current liabilities | 1,306,285 | |||
| Deferred revenue long term | 975,000 | |||
| Note payable related party-Nonrelated Party | 300,000 | |||
| Note payable related party-Related Party | 200,000 | |||
| Non-current portion of operating lease liabilities | 20,936 | |||
| Total liabilities | 2,802,221 | |||
| Common stock 0.0001 par value 100,000,000 shares authorized 48,179,039 and 46,816,114 shares issued and outstanding at december 31, 2025 and 2024, respectively | 4,818 | |||
| Additional paid-in capital | 33,810,785 | |||
| Accumulated deficit | -34,772,162 | |||
| Total stockholders' equity (deficit) | -956,559 | |||
| Total liabilities and stockholders' equity (deficit) | 1,845,662 | |||
Nuo Therapeutics, Inc. (AURX)
Nuo Therapeutics, Inc. (AURX)